The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Granulomatosis of Wegener’s

The Granulomatosis of Wegener’s

May 16, 2011 • By Wolfgang L. Gross, MD, PhD, Antje Mueller, PhD, and Julia Holle, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

PMN, aggregating to neutrophilic microabscesses (see the left panel of Figure 2, p. 41)—frequently in the center of epitheloid cell granulomas—undergo cell death, eventually forming areas of geographic necrosis.20 This cell death may occur via NETosis, a cell death program that could play a central role in the induction of autoimmunity.22

You Might Also Like
  • Granulomatosis with Polyangiitis: A Case Review
  • Wegener’s Granulomatosis Treatment Today
  • The Classification & Diagnosis of Granulomatosis with Polyangiitis
Explore This Issue
May 2011

Within the inflammatory lesions of granulomatous WG, lymphocytes together with follicular dendritic cells form germinal center-like structures (see the right panel of Figure 2, p. 41), a process very similar to rheumatoid synovium. These follicular structures provide a microenvironment for the development of autoreactive B cells (see below), which may link both hallmarks of WG, the granulomatous lesion as a site of autoantibody production and the autoimmune vasculitis. Surprisingly, another pathogenic process takes place in the granulomatous lesion (i.e., cartilage) (see the right panel of Figure 1, p. 41) and bone destruction (see the right panel of Figure 2, p. 41). This process has marked similarity to events in the rheumatoid synovium.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Autoantigens and Autoantibodies in the Granulomatous Lesion

Autoantibodies to constituents of PMN (e.g., PR3 [PR3-ANCA] or myeloperoxidase [MPO] [MPO-ANCA]) are the serological hallmarks of systemic vasculitis, and PR3-ANCA is strongly associated with WG. PR3 and MPO are abundant in neutrophil extracellular traps (NETs) formed by PMN that undergo nuclear disintegration and decondensation. NETs are web-like structures composed of chromatin bound to positively charged molecules (histones, neutrophil serine proteases). NETs play an important role physiologically and act in antimicrobial defense carried out by PMN.23 NETs have been found in glomerulonephritis of WG both in situ and in the bloodstream.24 Excess formation of NETs and their presentation of a modified PR3 also suggest a way by which dying PMN present in microabscesses and contribute to the necrotic areas in the granulomatous lesion and a subsequent rise of PR3-ANCA.20,25 In addition, a NETs-mediated release of factors such as B-lymphocyte stimulator by PMN could, for instance, promote the activation of B cells.26

Figure 3: Schematic overview focusing on different aspects of T cell involvement in WG.
click for large version
Figure 3: Schematic overview focusing on different aspects of T cell involvement in WG. We postulated that WG occurs as localized disease with granuloma (tosis) that is mediated by a Th1-like immune response in the granulomatous lesion. Generalized disease is characterized by granulomatosis + vasculitis with a Th2-type immune response in the granulomatous lesion. However, newer findings report not only more T helper cell subsets than the ones shown here, but also support the idea of a more fluid T cell phenotypic view, including Th17 cells.35

We have reported that germinal center-like structures containing T and B cells are often found within granulomatous lesions and hypothesized that germinal center-like structures might be an important element of a microenvironment that supports autoantibody-producing plasma cells (see references 21, 27, and 28 for a review of this). Indeed, we showed an accumulation of heavy chain variable region immunglobulin gene mutations in the endonasal mucosa of WG, pointing towards an influence of local autoantigens, such as PR3 on the generation of autoimmunity.29

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Conditions, Vasculitis Tagged With: Diagnostic Criteria, granulomatosis with polyangiitis, Pathogenesis, Treatment, Wegener's GranulomatosisIssue: May 2011

You Might Also Like:
  • Granulomatosis with Polyangiitis: A Case Review
  • Wegener’s Granulomatosis Treatment Today
  • The Classification & Diagnosis of Granulomatosis with Polyangiitis
  • Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)